Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells

Journal of Virology

Volumn 88, Issue 24, 2014, Pages 14426-14439

  Lam, Eric ^a   Falck Pedersen, Erik ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CYCLIC GMP AMP SYNTHASE; DESMOGLEIN 2; INTERFERON REGULATORY FACTOR 3; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE; STAT1 PROTEIN; STIMULATOR OF INTERFERON GENE PROTEIN; TBK1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; IRF3 PROTEIN, HUMAN; MB21D1 PROTEIN, HUMAN; MPYS PROTEIN, HUMAN; NUCLEOTIDYLTRANSFERASE; TBK1 PROTEIN, HUMAN;

ADENOVIRUS; ANTIVIRAL RESPONSE; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE INDUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE EVASION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MOLECULAR RECOGNITION; NONHUMAN; SEROTYPE; TRANSCRIPTION INITIATION; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; CELL LINE; HOST PATHOGEN INTERACTION; HUMAN ADENOVIRUS C; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADENOVIRIDAE;

ADENOVIRUSES, HUMAN; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON REGULATORY FACTOR-3; MEMBRANE PROTEINS; NUCLEOTIDYLTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; VIRUS REPLICATION;

EID: 84911492464     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02608-14     Document Type: Article

References (84)

1. Lynch JP, III, Fishbein M, Echavarria M. 2011. Adenovirus. Semin. Respir. Crit. Care Med. 32:494-511. http://dx.doi.org/10.1055/s-0031-1283287.
2. Pham TTM, Burchette JL, Jr, Hale LP. 2003. Fatal disseminated adenovirus infections in immunocompromised patients. Am. J. Clin. Pathol. 120:575-583. http://dx.doi.org/10.1309/AWXDGNC5D70EN7YT.
3. Ip WW, Qasim W. 2013. Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv. Hematol. 2013: 176418. http://dx.doi.org/10.1155/2013/176418.
4. Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG, Falck-Pedersen E. 1997. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. U. S. A. 94:9814-9819. http://dx.doi.org/10.1073/pnas.94.18.9814.
5. Muruve DA, Barnes MJ, Stillman IE, Libermann TA. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976. http://dx.doi.org/10.1089/10430349950018364.
6. Trevejo JM, Marino MW, Philpott N, Josien R, Richards EC, Elkon KB, Falck-Pedersen E. 2001. TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc. Natl. Acad. Sci. U. S. A. 98:12162-12167. http://dx.doi.org/10.1073/pnas.211423598.
7. Yang Y, Li Q, Ertl HC, Wilson JM. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
8. Yang Y, Su Q, Wilson JM. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209-7212.
9. Beladi I, Pusztai R. 1967. Interferon-like substance produced in chick fibroblast cells inoculated with human adenoviruses. Z. Naturforsch. B 22:165-169.
10. Ho M, Kohler K. 1967. Studies on human adenoviruses as inducers of interferon in chick cells. Arch. Gesamte Virusforsch. 22:69-78. http://dx.doi.org/10.1007/BF01240504.
11. Toth M, Bakay M, Tarodi B, Toth S, Pusztai R, Beladi I. 1983. Different interferon-inducing ability of human adenovirus types in chick embryo cells. Acta Virol. 27:337-345.
12. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323. http://dx.doi.org/10.1126/science.275.5304.1320.
13. Gaggar A, Shayakhmetov DM, Lieber A. 2003. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:1408-1412. http://dx.doi.org/10.1038/nm952.
14. Wang H, Li ZY, Liu Y, Persson J, Beyer I, Moller T, Koyuncu D, Drescher MR, Strauss R, Zhang XB, Wahl JK, III, Urban N, Drescher C, Hemminki A, Fender P, Lieber A. 2011. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17:96-104. http://dx.doi.org/10.1038/nm.2270.
15. Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG. 1999. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 73:6056-6065.
16. Teigler JE, Kagan JC, Barouch DH. 2014. Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity. J. Virol. 88:10354-10363. http://dx.doi.org/10.1128/JVI.00936-14.
17. Zhu J, Huang X, Yang Y. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. J. Virol. 81:3170-3180. http://dx.doi.org/10.1128/JVI.02192-06.
18. Nociari M, Ocheretina O, Schoggins JW, Falck-Pedersen E. 2007. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 81:4145-4157. http://dx.doi.org/10.1128/JVI.02685-06.
19. Nociari M, Ocheretina O, Murphy M, Falck-Pedersen E. 2009. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. J. Virol. 83:4081-4091. http://dx.doi.org/10.1128/JVI.02591-08.
20. Fejer G, Drechsel L, Liese J, Schleicher U, Ruzsics Z, Imelli N, Greber UF, Keck S, Hildenbrand B, Krug A, Bogdan C, Freudenberg MA. 2008. Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog. 4:e1000208. http://dx.doi.org/10.1371/journal.ppat.1000208.
21. Lam E, Stein S, Falck-Pedersen E. 2014. Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J. Virol. 88:974-981. http://dx.doi.org/10.1128/JVI.02702-13.
22. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791. http://dx.doi.org/10.1126/science.1232458.
23. Gao P, Ascano M, Wu Y, Barchet W, Gaffney BL, Zillinger T, Serganov AA, Liu Y, Jones RA, Hartmann G, Tuschl T, Patel DJ. 2013. Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153:1094-1107. http://dx.doi.org/10.1016/j.cell.2013.04.046.
24. Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341:1390-1394. http://dx.doi.org/10.1126/science.1244040.
25. Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Rohl I, Hopfner KP, Ludwig J, Hornung V. 2013. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 498:380-384. http://dx.doi.org/10.1038/nature12306.
26. Gao P, Ascano M, Zillinger T, Wang W, Dai P, Serganov AA, Gaffney BL, Shuman S, Jones RA, Deng L, Hartmann G, Barchet W, Tuschl T, Patel DJ. 2013. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell 154:748-762. http://dx.doi.org/10.1016/j.cell.2013.07.023.
27. Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51:226-235. http://dx.doi.org/10.1016/j.molcel.2013.05.022.
28. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788-792. http://dx.doi.org/10.1038/nature08476.
29. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678. http://dx.doi.org/10.1038/nature07317.
30. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 101:233-238. http://dx.doi.org/10.1073/pnas.2237236100.
31. Servant MJ, Grandvaux N, ten Oever BR, Duguay D, Lin R, Hiscott J. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278:9441-9447. http://dx.doi.org/10.1074/jbc.M209851200.
32. Clement JF, Bibeau-Poirier A, Gravel SP, Grandvaux N, Bonneil E, Thibault P, Meloche S, Servant MJ. 2008. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J. Virol. 82:3984-3996. http://dx.doi.org/10.1128/JVI.02526-07.
33. Panne D, Maniatis T, Harrison SC. 2007. An atomic model of the interferon-beta enhanceosome. Cell 129:1111-1123. http://dx.doi.org/10.1016/j.cell.2007.05.019.
34. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11:997-1004. http://dx.doi.org/10.1038/ni.1932.
35. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B. 2011. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 9:363-375. http://dx.doi.org/10.1016/j.chom.2011.04.008.
36. Hansen K, Prabakaran T, Laustsen A, Jorgensen SE, Rahbaek SH, Jensen SB, Nielsen R, Leber JH, Decker T, Horan KA, Jakobsen MR, Paludan SR. 2014. Listeria monocytogenes induces IFNbeta expression through an IFI16-, cGAS-and STING-dependent pathway. EMBO J. 33: 1654-1666. http://dx.doi.org/10.15252/embj.201488029.
37. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. 2011. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12:959-965. http://dx.doi.org/10.1038/ni.2091.
38. Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS, Zaver SA, Schenk M, Zeng S, Zhong W, Liu ZJ, Modlin RL, Liu YJ, Cheng G. 2012. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMPand cyclic di-AMP to activate a type I interferonimmuneresponse. Nat. Immunol. 13:1155-1161. http://dx.doi.org/10.1038/ni.2460.
39. Basner-Tschakarjan E, Gaffal E, O'Keeffe M, Tormo D, Limmer A, Wagner H, Hochrein H, Tuting T. 2006. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J. Gene Med. 8:1300-1306. http://dx.doi.org/10.1002/jgm.964.
40. Cerullo V, Seiler MP, Mane V, Brunetti-Pierri N, Clarke C, Bertin TK, Rodgers JR, Lee B. 2007. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 15:378-385. http://dx.doi.org/10.1038/sj.mt.6300031.
41. McGuire KA, Barlan AU, Griffin TM, Wiethoff CM. 2011. Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species. J. Virol. 85:10806-10813. http://dx.doi.org/10.1128/JVI.00675-11.
42. Perreau M, Welles HC, Pellaton C, Gjoksi B, Potin L, Martin R, Harari A, Bett A, Casimiro D, Gall J, Barouch DH, Kremer EJ, Pantaleo G. 2012. The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes. J. Virol. 86:6279-6285. http://dx.doi.org/10.1128/JVI.00123-12.
43. Iacobelli-Martinez M, Nemerow GR. 2007. Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J. Virol. 81:1305-1312. http://dx.doi.org/10.1128/JVI.01926-06.
44. Wold WS. 1993. Adenovirus genes that modulate the sensitivity of virusinfected cells to lysis by TNF. J. Cell. Biochem. 53:329-335. http://dx.doi.org/10.1002/jcb.240530410.
45. Burgert HG, Ruzsics Z, Obermeier S, Hilgendorf A, Windheim M, Elsing A. 2002. Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol. Immunol. 269:273-318.
46. Hendrickx R, Stichling N, Koelen J, Kuryk L, Lipiec A, Greber UF. 2014. Innate immunity to adenovirus. Hum. Gene Ther. 25:265-284. http://dx.doi.org/10.1089/hum.2014.001.
47. Mahr JA, Gooding LR. 1999. Immune evasion by adenoviruses. Immunol. Rev. 168:121-130. http://dx.doi.org/10.1111/j.1600-065X.1999.tb01287.x.
48. Anderson KP, Fennie EH. 1987. Adenovirus early region 1A modulation of interferon antiviral activity. J. Virol. 61:787-795.
49. Reich N, Pine R, Levy D, Darnell JE, Jr. 1988. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J. Virol. 62:114-119.
50. Duerksen-Hughes P, Wold WS, Gooding LR. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193-4200.
51. Look DC, Roswit WT, Frick AG, Gris-Alevy Y, Dickhaus DM, Walter MJ, Holtzman MJ. 1998. Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871-880. http://dx.doi.org/10.1016/S1074-7613(00) 80652-4.
52. Miller DL, Rickards B, Mashiba M, Huang W, Flint SJ. 2009. The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription. J. Virol. 83:3591-3603. http://dx.doi.org/10.1128/JVI.02269-08.
53. Chahal JS, Qi J, Flint SJ. 2012. The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells. PLoS Pathog. 8:e1002853. http://dx.doi.org/10.1371/journal.ppat.1002853.
54. Chahal JS, Gallagher C, DeHart CJ, Flint SJ. 2013. The repression domain of the E1B 55-kilodalton protein participates in countering interferon-induced inhibition of adenovirus replication. J. Virol. 87:4432-4444. http://dx.doi.org/10.1128/JVI.03387-12.
55. Sparer TE, Tripp RA, Dillehay DL, Hermiston TW, Wold WS, Gooding LR. 1996. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70: 2431-2439.
56. Thimmappaya B, Weinberger C, Schneider RJ, Shenk T. 1982. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543-551. http://dx.doi.org/10.1016/0092-8674(82)90310-5.
57. Liao HJ, Kobayashi R, Mathews MB. 1998. Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins. Proc. Natl. Acad. Sci. U. S. A. 95:8514-8519. http://dx.doi.org/10.1073/pnas.95.15.8514.
58. Ferrari R, Su T, Li B, Bonora G, Oberai A, Chan Y, Sasidharan R, Berk AJ, Pellegrini M, Kurdistani SK. 2012. Reorganization of the host epigenome by a viral oncogene. Genome Res. 22:1212-1221. http://dx.doi.org/10.1101/gr.132308.111.
59. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK. 2008. Epigenetic reprogramming by adenovirus e1a. Science 321:1086-1088. http://dx.doi.org/10.1126/science.1155546.
60. Berk AJ. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685. http://dx.doi.org/10.1038/sj.onc.1209040.
61. Miller DL, Myers CL, Rickards B, Coller HA, Flint SJ. 2007. Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival. Genome Biol. 8:R58. http://dx.doi.org/10.1186/gb-2007-8-4-r58.
62. Dorer DE, Holtrup F, Fellenberg K, Kaufmann JK, Engelhardt S, Hoheisel JD, Nettelbeck DM. 2011. Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells- differences of relevance for adenoviral oncolysis. PLoS One 6:e27934. http://dx.doi.org/10.1371/journal.pone.0027934.
63. Zhao H, Dahlo M, Isaksson A, Syvanen AC, Pettersson U. 2012. The transcriptome of the adenovirus infected cell. Virology 424:115-128. http://dx.doi.org/10.1016/j.virol.2011.12.006.
64. Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. U. S. A. 95: 9837-9842. http://dx.doi.org/10.1073/pnas.95.17.9837.
65. Schoggins JW, Falck-Pedersen E. 2006. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity. J. Virol. 80:10634-10627. http://dx.doi.org/10.1128/JVI.01359-06.
66. Stein SC, Falck-Pedersen E. 2012. Sensing adenovirus infection: activation of interferon regulatory factor 3 inRAW264.7 cells. J. Virol. 86:4527-4537. http://dx.doi.org/10.1128/JVI.07071-11.
67. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
68. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta CT) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
69. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215. http://dx.doi.org/10.1093/nar/16.3.1215.
70. Gallaher SD, Berk AJ. 2013. A rapid Q-PCR titration protocol for adenovirus and helper-dependent adenovirus vectors that produces biologically relevant results. J. Virol. Methods 192:28-38. http://dx.doi.org/10.1016/j.jviromet.2013.04.013.
71. Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E. 2005. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. J. Virol. 79:11627-11637. http://dx.doi.org/10.1128/JVI.79.18.11627-11637.2005.
72. Konno H, Konno K, Barber GN. 2013. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155:688-698. http://dx.doi.org/10.1016/j.cell.2013.09.049.
73. Qureshi SA, Salditt-Georgieff M, Darnell JE, Jr. 1995. Tyrosinephosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. U. S. A. 92:3829-3833. http://dx.doi.org/10.1073/pnas.92.9.3829.
74. Thimmappaya B, Jones N, Shenk T. 1979. A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell 18: 947-954. http://dx.doi.org/10.1016/0092-8674(79)90207-1.
75. Bett AJ, Krougliak V, Graham FL. 1995. DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309. Virus Res. 39:75-82. http://dx.doi.org/10.1016/S0168-1702(95)00071-2.
76. Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A. 2000. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J. Virol. 74:2567-2583. http://dx.doi.org/10.1128/JVI.74.6.2567-2583.2000.
77. Guiducci C, Ghirelli C, Marloie-Provost MA, Matray T, Coffman RL, Liu YJ, Barrat FJ, Soumelis V. 2008. PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J. Exp. Med. 205:315-322. http://dx.doi.org/10.1084/jem.20070763.
78. Xu Z, Tian J, Smith JS, Byrnes AP. 2008. Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J. Virol. 82:11705-11713. http://dx.doi.org/10.1128/JVI.01320-08.
79. Rhee EG, Blattman JN, Kasturi SP, Kelley RP, Kaufman DR, Lynch DM, La Porte A, Simmons NL, Clark SL, Pulendran B, Greenberg PD, Barouch DH. 2011. Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors. J. Virol. 85: 315-323. http://dx.doi.org/10.1128/JVI.01597-10.
80. Hartman ZC, Kiang A, Everett RS, Serra D, Yang XY, Clay TM, Amalfitano A. 2007. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J. Virol. 81:1796-1812. http://dx.doi.org/10.1128/JVI.01936-06.
81. Leonard GT, Sen GC. 1997. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein. J. Virol. 71:5095-5101.
82. Fonseca GJ, Thillainadesan G, Yousef AF, Ablack JN, Mossman KL, Torchia J, Mymryk JS. 2012. Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 11:597-606. http://dx.doi.org/10.1016/j.chom.2012.05.005.
83. Takaki H, Oshiumi H, Sasai M, Kawanishi T, Matsumoto M, Seya T. 2009. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction. Eur. J. Immunol. 39:3469-3476. http://dx.doi.org/10.1002/eji.200939878.
84. Sohn SY, Hearing P. 2011. Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation. J. Virol. 85:7555-7562. http://dx.doi.org/10.1128/JVI.00513-11.